Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 16017-63-3
2. 2-[4-(phenylsulfonyl)piperazino]-1-ethanol
3. 2-[4-(benzenesulfonyl)piperazin-1-yl]ethanol
4. 2-[4-(benzenesulfonyl)piperazin-1-yl]ethan-1-ol
5. 2-[4-(phenylsulfonyl)piperazin-1-yl]ethanol
6. Bas 00623072
7. 2-(4-benzenesulfonyl-piperazin-1-yl)-ethanol
8. 1-piperazineethanol, 4-(phenylsulfonyl)-
9. Timtec1_002928
10. 1-(2-hydroxyethyl)-4-(phenylsulfonyl)piperazine
11. Oprea1_453562
12. Oprea1_770905
13. Mls001209462
14. Chembl257075
15. Schembl10979638
16. Dtxsid60349927
17. Hms1542f02
18. Hms2836h13
19. Mfcd01211968
20. Stk049042
21. Zinc19805488
22. Akos002910098
23. Smr000514808
24. Cs-0156056
25. Ft-0681155
26. 2-[4-(phenylsulfonyl)-1-piperazinyl]ethanol
27. D83850
28. Ag-690/11632137
29. Sr-01000325910
30. J-505863
31. Sr-01000325910-1
32. Brd-k03331866-001-01-2
| Molecular Weight | 270.35 g/mol |
|---|---|
| Molecular Formula | C12H18N2O3S |
| XLogP3 | 0.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 270.10381361 g/mol |
| Monoisotopic Mass | 270.10381361 g/mol |
| Topological Polar Surface Area | 69.2 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 339 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A KB-0742 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of KB-0742, including repackagers and relabelers. The FDA regulates KB-0742 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. KB-0742 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A KB-0742 supplier is an individual or a company that provides KB-0742 active pharmaceutical ingredient (API) or KB-0742 finished formulations upon request. The KB-0742 suppliers may include KB-0742 API manufacturers, exporters, distributors and traders.
KB-0742 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of KB-0742 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right KB-0742 GMP manufacturer or KB-0742 GMP API supplier for your needs.
A KB-0742 CoA (Certificate of Analysis) is a formal document that attests to KB-0742's compliance with KB-0742 specifications and serves as a tool for batch-level quality control.
KB-0742 CoA mostly includes findings from lab analyses of a specific batch. For each KB-0742 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
KB-0742 may be tested according to a variety of international standards, such as European Pharmacopoeia (KB-0742 EP), KB-0742 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (KB-0742 USP).
LOOKING FOR A SUPPLIER?
